Curdione, as a drug, was found to promote ferroptosis in cancer cells by up regulating the expression of METTL14 and YTHDF2, which in turn affected the expression levels of SLC7A11, SLC3A2, HOXA13 and GPX4180. Here, METTL14 is linked to cancer.